Evidence map›Paper›PMID 34008150›Full record

SynthesisInflammopharmacology2021

Effects of coenzyme Q10 supplementation on inflammation, angiogenesis, and oxidative stress in breast cancer patients: a systematic review and meta-analysis of randomized controlled- trials.

Mina Alimohammadi, Ali Rahimi, Fatemeh Faramarzi, Monireh Golpour, Reza Jafari-Shakib, Reza Alizadeh-Navaei, Alireza Rafiei

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Inflammopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 6 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 6 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Review
  10. Article
  11. Effects of coenzyme QClinical oral investigations · 2024
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Coenzyme Q10 Stimulate Reproductive Vatality.Drug design, development and therapy · 2023
    Review
  19. Review
  20. The Combined Clinical Diagnosis of TNF-Journal of oncology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Mina AlimohammadiDepartment of Immunology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Ali RahimiDepartment of Immunology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Fatemeh FaramarziDepartment of Immunology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Monireh GolpourDepartment of Immunology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Reza Jafari-ShakibMedical Biotechnology Research Center, School of Paramedicine, Guilan University of Medical Sciences, Rasht, Iran.
Reza Alizadeh-NavaeiGastrointestinal Cancer Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Alireza RafieiDepartment of Immunology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. rafiei1710@gmail.com.ORCID http://orcid.org/0000-0002-1766-6605
Mazandaran University of Medical Sciences · IRGuilan University of Medical Sciences · IRIran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectiveSystemic inflammation and oxidative stress (OS) are associated with breast cancer. CoQ10 as an adjuvant treatment with conventional anti-cancer chemotherapy has been demonstrated to help in the inflammatory process and OS. This systematic review and meta-analysis of randomized clinical trials (RCTs) aimed to evaluate the efficacy of CoQ10 supplementation on levels of inflammatory markers, OS parameters, and matrix metalloproteinases/tissue inhibitor of metalloproteinases (MMPs/TIMPs) in patients with breast cancer.

methodsA systematic literature search was carried out using electronic databases, including PubMed, Web of Science, Scopus, Google Scholar, and Embase, up to December 2020 to identify eligible RCTs evaluating the effect of CoQ10 supplementation on OS biomarkers, inflammatory cytokines, and MMPs/TIMPs. From 827 potential reports, 5 eligible studies consisting of 9 trials were finally included in the current meta-analysis. Quality assessment and heterogeneity tests of the selected trials were performed using the PRISMA checklist protocol and the I

resultsOur meta-analysis of the pooled findings for inflammatory biomarkers of OS and MMPs showed that CoQ10 supplementation (100 mg/day for 45-90 days) significantly decreased the levels of VEGF [SMD: - 1.88, 95% CI: (- 2. 62 to - 1.13); I

conclusionOverall, the findings showed that CoQ10 supplementation reduced some of the important markers of inflammation and MMPs in patients with breast cancer. However, further studies with controlled trials for other types of cancer are needed to better understand and confirm the effect of CoQ10 on tumor therapy.

Indexed as

Angiogenesis InhibitorsBreast NeoplasmsDietary SupplementsFemaleHumansInflammationInflammation MediatorsMatrix Metalloproteinase InhibitorsMatrix MetalloproteinasesOxidative StressRandomized Controlled Trials as TopicTissue Inhibitor of MetalloproteinasesTreatment OutcomeUbiquinoneAngiogenesis Inhibitorscoenzyme Q10Inflammation MediatorsMatrix Metalloproteinase InhibitorsMatrix MetalloproteinasesTissue Inhibitor of MetalloproteinasesUbiquinoneBreast cancerCoenzyme Q10 (CoQ10)Inflammatory cytokinesMatrix metalloproteinases (MMPs)Oxidative stress (OS)Tissue inhibitor of metalloproteinases (TIMPs)

Identifiers

PMID34008150
OpenAlexW3162901975

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.